CN101856480A - Chinese medicament for treating myocardial infarction - Google Patents
Chinese medicament for treating myocardial infarction Download PDFInfo
- Publication number
- CN101856480A CN101856480A CN201010189005A CN201010189005A CN101856480A CN 101856480 A CN101856480 A CN 101856480A CN 201010189005 A CN201010189005 A CN 201010189005A CN 201010189005 A CN201010189005 A CN 201010189005A CN 101856480 A CN101856480 A CN 101856480A
- Authority
- CN
- China
- Prior art keywords
- parts
- grams
- radix
- rhizoma
- myocardial infarction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000010125 myocardial infarction Diseases 0.000 title claims abstract description 17
- 239000003814 drug Substances 0.000 title claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 241000628997 Flos Species 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 241000717739 Boswellia sacra Species 0.000 claims description 5
- 239000008589 Cortex Fraxini Substances 0.000 claims description 5
- 241000218176 Corydalis Species 0.000 claims description 5
- 244000166124 Eucalyptus globulus Species 0.000 claims description 5
- 235000004692 Eucalyptus globulus Nutrition 0.000 claims description 5
- 241001489978 Eupolyphaga Species 0.000 claims description 5
- 239000004863 Frankincense Substances 0.000 claims description 5
- 241001057584 Myrrha Species 0.000 claims description 5
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 5
- 241000180649 Panax notoginseng Species 0.000 claims description 5
- 239000009670 cang er zi wan Substances 0.000 claims description 5
- 239000009969 fructus bruceae Substances 0.000 claims description 5
- 229940056582 human hair preparation Drugs 0.000 claims description 5
- 239000009806 pulsatillae Substances 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 10
- 239000000203 mixture Substances 0.000 abstract description 5
- 208000002193 Pain Diseases 0.000 abstract description 2
- 230000004089 microcirculation Effects 0.000 abstract description 2
- 208000031225 myocardial ischemia Diseases 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241001313855 Bletilla Species 0.000 abstract 1
- 240000008365 Celosia argentea Species 0.000 abstract 1
- 235000000722 Celosia argentea Nutrition 0.000 abstract 1
- 241000233839 Commelina communis Species 0.000 abstract 1
- 244000163122 Curcuma domestica Species 0.000 abstract 1
- 241001135871 Gentiana scabra Species 0.000 abstract 1
- 241000735470 Juncus Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 241000218378 Magnolia Species 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 241000123069 Ocyurus chrysurus Species 0.000 abstract 1
- 240000004064 Poterium sanguisorba Species 0.000 abstract 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 abstract 1
- 244000086363 Pterocarpus indicus Species 0.000 abstract 1
- 235000009984 Pterocarpus indicus Nutrition 0.000 abstract 1
- 241000442474 Pulsatilla vulgaris Species 0.000 abstract 1
- 244000097577 Rhus javanica Species 0.000 abstract 1
- 235000010889 Rhus javanica Nutrition 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 244000197975 Solidago virgaurea Species 0.000 abstract 1
- 240000000260 Typha latifolia Species 0.000 abstract 1
- 230000001914 calming effect Effects 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- 210000005259 peripheral blood Anatomy 0.000 abstract 1
- 239000011886 peripheral blood Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000002023 wood Substances 0.000 abstract 1
- 230000003203 everyday effect Effects 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 210000004165 myocardium Anatomy 0.000 description 5
- 206010002383 Angina Pectoris Diseases 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 3
- 206010028851 Necrosis Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 206010008479 Chest Pain Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000009692 acute damage Effects 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese medicinal composition, in particular to a Chinese medicament for treating myocardial infarction, which is prepared from the following raw materials in part by weight: 3 to 5 parts of siberian cocklour fruit, 4 to 6 parts of biond magnolia flower, 4 to 6 parts of folium eucalypti, 2 to 4 parts of golden-rod solidago, 3 to 5 parts of common dayflower herb, 2 to 4 parts of feather cockscomb seed, 1 to 3 parts of gentiana scabra bge, 2 to 4 parts of densefruit pittany root-bark, 1 to 3 parts of ash bark, 2 to 4 parts of rhizome paridis, 2 to 4 parts of juncus pith, 1 to 3 parts of java brucea fruit, 3 to 5 parts of Chinese pasque-flower, 4 to 6 parts of lotus rhizome node, 1 to 3 parts of cattail pollen, 1 to 3 parts of India madder root, 2 to 4 parts of rosewood heart wood, 3 to 5 parts of carbonized human hair, 2 to 4 parts of garden burnet root, 2 to 4 parts of common bletilla pseudobulb, 3 to 5 parts of szechuan lovage rhizome, 1 to 3 parts of yanhusuo, 1 to 3 parts of radix curcumae and 3 to 5 parts of curcuma longa. The Chinese medicinal composition has the advantages of good curative effect, quick response, small administration dosage, convenient use and no toxic or side effect, and has the effects of calming and stopping pain, improving microcirculation, reducing the resistance of peripheral blood vessels, relieving cardiac stress and improving myocardial ischemia.
Description
(1) technical field
The present invention relates to Chinese medicine composition, particularly a kind of Chinese medicine for the treatment of myocardial infarction.
(2) background technology
Myocardial infarction, angina pectoris are that human sickness rate is the highest, the disease that mortality rate is the highest.And along with development of human society, the change of living environment, the quickening of rhythm of life, the increase of life stress, the sickness rate of myocardial infarction, angina pectoris disease is in rising trend.Myocardial infarction is meant the ischemic necrosis of cardiac muscle, and on the basis of coronary artery pathological changes, blood flow coronarius sharply reduces or interrupts, and makes corresponding cardiac muscle seriously and enduringly acute ischemia occur, finally causes the ischemic necrosis of cardiac muscle.The patient of acute myocardial infarction is taken place, often have clinically have an intense pain behind the persistent breastbone, heating, numeration of leukocyte are increased, the serum myocardium enzyme raises and electrocardiogram reflecting myocardium acute injury, ischemia and downright bad series of features differentiation, and arrhythmia, shock or heart failure can appear, belong to the serious type of coronary heart disease.The reason of myocardial infarction, majority are coronary atherosclerotic score piece or thrombosis on this basis, cause due to vessel lumen stops up.At present, a lot of to myocardial infarction, anginal Chinese medicine and western medicine, but all there are pros and cons in various degree to exist.
(3) summary of the invention
The present invention is in order to remedy the deficiencies in the prior art, and the Chinese medicine of a kind of good effect, instant effect, easy to use, the treatment myocardial infarction that has no side effect is provided.
The present invention is achieved through the following technical solutions:
The Chinese medicine of treatment myocardial infarction of the present invention, its special character is: the raw material by following parts by weight is made: Fructus Xanthii 3-5 part, Flos Magnoliae 4-6 part, Folium eucalypti globueli (Eucalyptus globulus Labill.) 4-6 part, Herba Solidaginis 2-4 part, Herba Commelinae 3-5 part, Semen Celosiae 2-4 part, Radix Gentianae 1-3 part, Cortex Dictamni 2-4 part, Cortex Fraxini 1-3 part, Rhizoma Paridis 2-4 part, Medulla Junci 2-4 part, Fructus Bruceae 1-3 part, Radix Pulsatillae 3-5 part, Nodus Nelumbinis Rhizomatis 4-6 part, Pollen Typhae 1-3 part, Radix Rubiae 1-3 part, Lignum Dalbergiae Odoriferae 2-4 part, Crinis Carbonisatus 3-5 part, Radix Sanguisorbae 2-4 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 2-4 part, Rhizoma Chuanxiong 3-5 part, Rhizoma Corydalis 1-3 part, Radix Curcumae 1-3 part, Rhizoma Curcumae Longae 3-5 part, Olibanum 2-4 part, Myrrha 2-4 part, Radix Salviae Miltiorrhizae 2-4 part, Semen Persicae 1-3 part, Flos Carthami 1-3 part, Radix Notoginseng 4-6 part, Eupolyphaga Seu Steleophaga 3-5 part.
Cure mainly indication: myocardial infarction, coronary heart disease, angina pectoris.
Preparation method: raw material is added water soaked 30 minutes for 1000 parts, be placed in the glass boiler and boil, continue 30-40 minute, medical filtration is come out, filtering residue is added 1000 parts in water, be placed in the glass boiler and boil, continue 30-40 minute, medical filtration is come out, behind twice medicinal liquid mix homogeneously, be equally divided into two parts.
Usage and dosage: every day, each once took portion at every turn sooner or later, and taking two parts every day is potion, took 1-2 the course of treatment and cured, and be 30 days each course of treatment.
Data is summed up in clinical research
The present invention is through carrying out clinical observation treatment to 100 routine patients, male's 65 examples wherein, and women's 35 examples, the age 30 is to 70 years old, wherein, acute and chronic myocardial infarction 70 examples, coronary heart disease 20 examples, angina pectoris 10 examples.
(1) Therapeutic Method:
Oral, every day, each once took portion at every turn sooner or later, and taking two parts every day is potion, took 1-2 the course of treatment and cured, and be 30 days each course of treatment.
(2) efficacy assessment standard:
Cure: clinical symptoms signs such as retrosternal pain, arrhythmia, shock, heating disappear, and it is normal that functional activity recovers.
Produce effects: the basic or big portion of clinical symptoms sign disappears.
Effectively: clinical symptoms is clearly better or takes a turn for the better.
Invalid: the clinical symptoms sign does not have improvement.
(3) therapeutic effect:
Clinical cure 95 examples account for 95%; Produce effects 3 examples account for 3%; Effective 1 example accounts for 1%; Invalid 1 example accounts for 1%; Total effective rate 99%.
The invention has the beneficial effects as follows, good effect, instant effect, taking dose is little, and is easy to use, has no side effect, and has sedation-analgesia, and microcirculation improvement reduces peripheral vascular resistance, and lightening heart load improves the effect of myocardial ischemia.
(4) specific embodiment
Embodiment 1
The Chinese medicine of treatment myocardial infarction of the present invention is made by the raw material of following weight: Fructus Xanthii 4 grams, Flos Magnoliae 5 grams, Folium eucalypti globueli (Eucalyptus globulus Labill.) 5 grams, Herba Solidaginis 3 grams, Herba Commelinae 4 grams, Semen Celosiae 3 grams, Radix Gentianae 2 grams, Cortex Dictamni 3 grams, Cortex Fraxini 2 grams, Rhizoma Paridis 3 grams, Medulla Junci 3 grams, Fructus Bruceae 2 grams, the Radix Pulsatillae 4 grams, Nodus Nelumbinis Rhizomatis 5 grams, Pollen Typhae 2 grams, Radix Rubiae 2 grams, Lignum Dalbergiae Odoriferae 3 grams, Crinis Carbonisatus 4 grams, Radix Sanguisorbae 3 grams, Pseudobulbus Bletillae (Rhizoma Bletillae) 3 grams, Rhizoma Chuanxiong 4 grams, Rhizoma Corydalis 2 grams, Radix Curcumae 2 grams, Rhizoma Curcumae Longae 4 grams, Olibanum 3 grams, Myrrha 3 grams, Radix Salviae Miltiorrhizae 3 grams, Semen Persicae 2 grams, Flos Carthami 2 grams, Radix Notoginseng 5 grams, Eupolyphaga Seu Steleophaga 4 grams.
Preparation method: raw material is added water 1000 grams soaked 30 minutes, be placed in the glass boiler and boil, continue 30-40 minute, medical filtration is come out, filtering residue is added water 1000 grams, be placed in the glass boiler and boil, continue 30-40 minute, medical filtration is come out, behind twice medicinal liquid mix homogeneously, be equally divided into two parts.
Usage and dosage: every day, each once took portion at every turn sooner or later, and taking two parts every day is potion, took 1-2 the course of treatment and cured, and be 30 days each course of treatment.
Embodiment 2
The Chinese medicine of treatment myocardial infarction of the present invention is made by the raw material of following weight: Fructus Xanthii 3 grams, Flos Magnoliae 4 grams, Folium eucalypti globueli (Eucalyptus globulus Labill.) 4 grams, Herba Solidaginis 2 grams, Herba Commelinae 3 grams, Semen Celosiae 2 grams, Radix Gentianae 1 gram, Cortex Dictamni 2 grams, Cortex Fraxini 1 gram, Rhizoma Paridis 2 grams, Medulla Junci 2 grams, Fructus Bruceae 1 gram, the Radix Pulsatillae 3 grams, Nodus Nelumbinis Rhizomatis 4 grams, Pollen Typhae 1 gram, Radix Rubiae 1 gram, Lignum Dalbergiae Odoriferae 2 grams, Crinis Carbonisatus 3 grams, Radix Sanguisorbae 2 grams, Pseudobulbus Bletillae (Rhizoma Bletillae) 2 grams, Rhizoma Chuanxiong 3 grams, Rhizoma Corydalis 1 gram, Radix Curcumae 1 gram, Rhizoma Curcumae Longae 3 grams, Olibanum 2 grams, Myrrha 2 grams, Radix Salviae Miltiorrhizae 2 grams, Semen Persicae 1 gram, Flos Carthami 1 gram, Radix Notoginseng 4 grams, Eupolyphaga Seu Steleophaga 3 grams.
All the other are identical with embodiment 1.
Embodiment 3
The Chinese medicine of treatment myocardial infarction of the present invention is made by the raw material of following weight: Fructus Xanthii 5 grams, Flos Magnoliae 6 grams, Folium eucalypti globueli (Eucalyptus globulus Labill.) 6 grams, Herba Solidaginis 4 grams, Herba Commelinae 5 grams, Semen Celosiae 4 grams, Radix Gentianae 3 grams, Cortex Dictamni 4 grams, Cortex Fraxini 3 grams, Rhizoma Paridis 4 grams, Medulla Junci 4 grams, Fructus Bruceae 3 grams, the Radix Pulsatillae 5 grams, Nodus Nelumbinis Rhizomatis 6 grams, Pollen Typhae 3 grams, Radix Rubiae 3 grams, Lignum Dalbergiae Odoriferae 4 grams, Crinis Carbonisatus 5 grams, Radix Sanguisorbae 4 grams, Pseudobulbus Bletillae (Rhizoma Bletillae) 4 grams, Rhizoma Chuanxiong 5 grams, Rhizoma Corydalis 3 grams, Radix Curcumae 3 grams, Rhizoma Curcumae Longae 5 grams, Olibanum 4 grams, Myrrha 4 grams, Radix Salviae Miltiorrhizae 4 grams, Semen Persicae 3 grams, Flos Carthami 3 grams, Radix Notoginseng 6 grams, Eupolyphaga Seu Steleophaga 5 grams.
All the other are identical with embodiment 1.
Claims (1)
1. Chinese medicine for the treatment of myocardial infarction, it is characterized in that: the raw material by following parts by weight is made: Fructus Xanthii 3-5 part, Flos Magnoliae 4-6 part, Folium eucalypti globueli (Eucalyptus globulus Labill.) 4-6 part, Herba Solidaginis 2-4 part, Herba Commelinae 3-5 part, Semen Celosiae 2-4 part, Radix Gentianae 1-3 part, Cortex Dictamni 2-4 part, Cortex Fraxini 1-3 part, Rhizoma Paridis 2-4 part, Medulla Junci 2-4 part, Fructus Bruceae 1-3 part, Radix Pulsatillae 3-5 part, Nodus Nelumbinis Rhizomatis 4-6 part, Pollen Typhae 1-3 part, Radix Rubiae 1-3 part, Lignum Dalbergiae Odoriferae 2-4 part, Crinis Carbonisatus 3-5 part, Radix Sanguisorbae 2-4 part, Pseudobulbus Bletillae (Rhizoma Bletillae) 2-4 part, Rhizoma Chuanxiong 3-5 part, Rhizoma Corydalis 1-3 part, Radix Curcumae 1-3 part, Rhizoma Curcumae Longae 3-5 part, Olibanum 2-4 part, Myrrha 2-4 part, Radix Salviae Miltiorrhizae 2-4 part, Semen Persicae 1-3 part, Flos Carthami 1-3 part, Radix Notoginseng 4-6 part, Eupolyphaga Seu Steleophaga 3-5 part.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101890055A CN101856480B (en) | 2010-06-01 | 2010-06-01 | Chinese medicament for treating myocardial infarction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101890055A CN101856480B (en) | 2010-06-01 | 2010-06-01 | Chinese medicament for treating myocardial infarction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101856480A true CN101856480A (en) | 2010-10-13 |
| CN101856480B CN101856480B (en) | 2011-08-10 |
Family
ID=42942784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101890055A Expired - Fee Related CN101856480B (en) | 2010-06-01 | 2010-06-01 | Chinese medicament for treating myocardial infarction |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101856480B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103202995A (en) * | 2013-04-17 | 2013-07-17 | 孙雪林 | Traditional Chinese medicine for treating myocardial infarction |
| CN103272175A (en) * | 2013-05-28 | 2013-09-04 | 高志芳 | Traditional Chinese medicine for treating myocardial infarction and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074613A (en) * | 1993-01-18 | 1993-07-28 | 邱天道 | Xintai paste for heart safety |
| CN1125112A (en) * | 1994-12-22 | 1996-06-26 | 崔素兴 | Application of traditional Chinese medicine in course of preparing drug for curing hypertension |
| CN1223122A (en) * | 1998-01-13 | 1999-07-21 | 彭文瑞 | Medicine for curing cerebrovascular and cardiovascular diseases and preparation process thereof |
| CN1319404A (en) * | 2000-12-23 | 2001-10-31 | 薛志祥 | Medicine for treating coronary heart disease |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | A kind of Tongxinluo medicinal composition and its application |
-
2010
- 2010-06-01 CN CN2010101890055A patent/CN101856480B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1074613A (en) * | 1993-01-18 | 1993-07-28 | 邱天道 | Xintai paste for heart safety |
| CN1125112A (en) * | 1994-12-22 | 1996-06-26 | 崔素兴 | Application of traditional Chinese medicine in course of preparing drug for curing hypertension |
| CN1223122A (en) * | 1998-01-13 | 1999-07-21 | 彭文瑞 | Medicine for curing cerebrovascular and cardiovascular diseases and preparation process thereof |
| CN1319404A (en) * | 2000-12-23 | 2001-10-31 | 薛志祥 | Medicine for treating coronary heart disease |
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | A kind of Tongxinluo medicinal composition and its application |
Non-Patent Citations (4)
| Title |
|---|
| 《中国中医急症》 20021031 罗新民等 益心活血汤为主治疗剂型心肌梗塞42例 404 1 第11卷, 第5期 2 * |
| 《实用中医内科杂志》 20071231 梁晨 中西医结合治疗急性心肌梗塞90例 55-56 1 第21卷, 第6期 2 * |
| 《河南中医学院学报》 20071130 丁应梅 中医治疗急性心肌梗塞的远期疗效观察 48 1 第22卷, 第6期 2 * |
| 《现代康复》 19981231 陆晓江 对心绞痛、心肌梗塞的辨证论治 570-571 1 第2卷, 第6期 2 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103202995A (en) * | 2013-04-17 | 2013-07-17 | 孙雪林 | Traditional Chinese medicine for treating myocardial infarction |
| CN103202995B (en) * | 2013-04-17 | 2015-03-11 | 孙雪林 | Traditional Chinese medicine for treating myocardial infarction |
| CN103272175A (en) * | 2013-05-28 | 2013-09-04 | 高志芳 | Traditional Chinese medicine for treating myocardial infarction and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101856480B (en) | 2011-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102106974A (en) | Oral liquid for healing hemiplegia | |
| CN101569672A (en) | Golden brain powder | |
| CN100382839C (en) | Chinese-medicinal composition for treating coronary heart disease | |
| CN101919944B (en) | Traditional Chinese medicine compound, preparation method and application thereof | |
| CN101433689A (en) | Kudzu root and longstamen onion bulb oral liquid and preparation method | |
| CN101856480B (en) | Chinese medicament for treating myocardial infarction | |
| CN103142849B (en) | Chinese medicine preparation for treating acute vital myocarditis | |
| CN101658636B (en) | Chinese medical composition for treating coronary heart disease | |
| CN103550356B (en) | Traditional Chinese medicinal composition for treating thrombus | |
| CN101810771A (en) | Chinese medicinal preparation for curing coronary heart disease and angina pectoris | |
| CN103272175B (en) | Traditional Chinese medicine for treating myocardial infarction and preparation method thereof | |
| CN1321484A (en) | Medicine for curing coronary heart disease with hypertension and its preparation process | |
| CN101199667A (en) | Chinese medicine for treating leukemia, aplastic anemia | |
| CN101439151B (en) | Medicament for treating beriberi | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN105687619A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN101658661A (en) | Chinese medicinal composition having effect of promoting blood circulation and removing blood stasis | |
| CN102716293A (en) | Capsule for treating hypertension, hyperlipemia, arteriosclerosis and coronary heart disease | |
| CN103656129A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN101559134A (en) | Chinese materia medica preparation for treating rosacea | |
| CN1294961C (en) | Oral liquid for curing myocardial ischemia and process for preparing the same | |
| CN102861244A (en) | Traditional Chinese medicine compound for treating cardia-cerebrovascular disease | |
| CN102266447B (en) | Chinese medicinal composition for treating coronary heart disease | |
| CN100381160C (en) | Chinese medicine for treating B-type hepatitis | |
| CN108704064A (en) | A kind of Chinese medicine composition and preparation method for treating AIDS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110810 Termination date: 20120601 |